EPO and chronic kidney disease: Furthermore, in one model of CKD, it was seen that renal EPO-producing cells (REPs) contribute to the final common pathway of fibrosis through transforming into collagen-producing myofibroblasts, thereby losing their EPO-producing capacity [26].